All Stories

  1. Metacognitive Therapy in Cardiac Rehabilitation: Staff Barriers and Enablers to Training in an Evidence‐Based Psychological Treatment for Anxiety and Depression
  2. Metacognitive beliefs in health anxiety: psychometric evaluation of the MCQ-HA and a test of the metacognitive model applied to health anxiety in a Norwegian sample
  3. Metacognitive therapy and work-focus for patients with depression, anxiety or comorbid depression and anxiety on sick leave: a single-centre, open-label randomised controlled trial
  4. Do Parental Psychopathology and Higher‐Order Beliefs Predict Symptom Changes in Young People Following Metacognitive Therapy?
  5. Relationships between anxiety, depression and wound healing outcomes in adults: A systematic review and meta-analysis
  6. Cost-effectiveness of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression: analysis of a randomised controlled trial
  7. Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: The PATHWAY Research Programme Including 4 RCTs
  8. Relationships between metacognitive beliefs and anxiety and depression in children and adolescents: A meta-analysis
  9. Cardiac rehabilitation for children and young people (CardioActive): protocol for a single-blind randomised feasibility and acceptability study of a centre-based cardiac rehabilitation programme versus usual care in 11–16 years with heart conditions
  10. Metacognitive therapy home-based self-help for anxiety and depression in cardiovascular disease patients in the UK: A single-blind randomised controlled trial
  11. A framework for implementing Patient and Public Involvement in mental health research: The PATHWAY research programme benchmarked against NIHR standards
  12. The Effectiveness of Metacognitive Therapy Compared to Behavioral Activation for Severely Depressed Outpatients: A Single-Center Randomized Trial
  13. Discrete choice experiment to investigate preferences for psychological intervention in cardiac rehabilitation
  14. Youth Metacognitive Therapy (YoMeta): protocol for a single-blind randomised feasibility trial of a transdiagnostic intervention versus treatment as usual in 11–16-year-olds with common mental health problems
  15. Evaluating Metacognitive Therapy to Improve Treatment of Anxiety and Depression in Cardiovascular Disease: The NIHR Funded PATHWAY Research Programme
  16. Self-help metacognitive therapy for anxiety and depression in heart patients
  17. Metacognitive therapy and work-focused interventions for patients on sick leave due to anxiety and depression: study protocol for a randomised controlled wait-list trial
  18. Metacognitive Beliefs and Suicidal Ideation: An Experience Sampling Study
  19. Metacognition, rumination and suicidal ideation: An experience sampling test of the self-regulatory executive function model
  20. Improving the Effectiveness of Psychological Interventions for Depression and Anxiety in Cardiac Rehabilitation: PATHWAY—A Single-Blind, Parallel, Randomized, Controlled Trial of Group Metacognitive Therapy
  21. Cardiac rehabilitation patients experiences and understanding of group metacognitive therapy: a qualitative study
  22. Covid-19, Lockdown and Self-Isolation: Evaluation of Deliberate Self-Harm Admissions
  23. Metacognitive beliefs and their relationship with anxiety and depression in physical illnesses: A systematic review
  24. Protocol for the economic evaluation of metacognitive therapy for cardiac rehabilitation participants with symptoms of anxiety and/or depression
  25. Utilising Patient and Public Involvement in Stated Preference Research in Health: Learning from the Existing Literature and a Case Study
  26. Author Correction: Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial
  27. Establishing the Feasibility of Group Metacognitive Therapy for Anxiety and Depression in Cardiac Rehabilitation: A Single-Blind Randomized Pilot Study
  28. Metacognition in Cardiac Patients With Anxiety and Depression: Psychometric Performance of the Metacognitions Questionnaire 30 (MCQ-30)
  29. Metacognitive Therapy versus Cognitive Behaviour Therapy in Adults with Major Depression: A Parallel Single-Blind Randomised Trial
  30. Metacognitive Therapy for Depression: A 3-Year Follow-Up Study Assessing Recovery, Relapse, Work Force Participation, and Quality of Life
  31. Breaking the Cybernetic Code: Understanding and Treating the Human Metacognitive Control System to Enhance Mental Health
  32. What Comes First Metacognition or Negative Emotion? A Test of Temporal Precedence
  33. Measuring the Cognitive Attentional Syndrome in Cardiac Patients With Anxiety and Depression Symptoms: Psychometric Properties of the CAS-1R
  34. Testing relationships between metacognitive beliefs, anxiety and depression in cardiac and cancer patients: Are they transdiagnostic?
  35. A Comparison of Metacognitive Therapy in Current Versus Persistent Depressive Disorder – A Pilot Outpatient Study
  36. Metacognitive Therapy of Early Traumatized Patients With Borderline Personality Disorder: A Phase-II Baseline Controlled Trial
  37. A Preliminary Evaluation of Transdiagnostic Group Metacognitive Therapy in a Mixed Psychological Disorder Sample
  38. Modeling the Relationships Between Metacognitive Beliefs, Attention Control and Symptoms in Children With and Without Anxiety Disorders: A Test of the S-REF Model
  39. Cardiac Rehabilitation Patients’ Accounts of Their Emotional Distress and Psychological Needs: A Qualitative Study
  40. Metacognition, Hardiness, and Grit as Resilience Factors in Unmanned Aerial Systems (UAS) Operations: A Simulation Study
  41. In or out of work: A preliminary investigation of mental health, trait anxiety and metacognitive beliefs as predictors of work status
  42. What Lies Beneath Trait-Anxiety? Testing the Self-Regulatory Executive Function Model of Vulnerability
  43. Qualitative Analysis of Emotional Distress in Cardiac Patients From the Perspectives of Cognitive Behavioral and Metacognitive Theories: Why Might Cognitive Behavioral Therapy Have Limited Benefit, and Might Metacognitive Therapy Be More Effective?
  44. Metacognitive Therapy for Alcohol Use Disorder: A Systematic Case Series
  45. Group Cognitive-Behavior Therapy or Group Metacognitive Therapy for Obsessive-Compulsive Disorder? Benchmarking and Comparative Effectiveness in a Routine Clinical Service
  46. Single Dose of the Attention Training Technique Increases Resting Alpha and Beta-Oscillations in Frontoparietal Brain Networks: A Randomized Controlled Comparison
  47. Metacognitive therapy (MCT) vs. Cognitive behavioural therapy (CBT) in generalised anxiety disorder
  48. Brief Cognitive Therapy Plus Treatment as Usual for Social Anxiety Disorder: a Randomized Trial of Adults in India
  49. Metacognitive therapy home-based self-help for cardiac rehabilitation patients experiencing anxiety and depressive symptoms: study protocol for a feasibility randomised controlled trial (PATHWAY Home-MCT)
  50. Effects of the Attention Training Technique on Auditory Hallucinations in Schizo-Affective Disorder: A Single Case Study
  51. Assessment of metacognitive beliefs in an at risk mental state for psychosis: A validation study of the Metacognitions Questionnaire-30
  52. Letter to the editor: Metacognitive therapy or metacognitive training: What's in a name?
  53. The Attention Training Technique improves Children's ability to delay gratification: A controlled comparison with progressive relaxation
  54. Cost-effectiveness of cardiac rehabilitation: a systematic review
  55. Metacognitive Therapy for Social Anxiety Disorder: An A–B Replication Series Across Social Anxiety Subtypes
  56. Improving the effectiveness of psychological interventions for depression and anxiety in the cardiac rehabilitation pathway using group-based metacognitive therapy (PATHWAY Group MCT): study protocol for a randomised controlled trial
  57. Metacognitive beliefs as psychological predictors of social functioning: An investigation with young people at risk of psychosis
  58. Explaining depression symptoms in patients with social anxiety disorder: Do maladaptive metacognitive beliefs play a role?
  59. Worry and rumination: do they prolong physiological and affective recovery from stress?
  60. Metacognitive therapy vs. eye movement desensitization and reprocessing for posttraumatic stress disorder: study protocol for a randomized superiority trial
  61. Neurophysiological correlates of the attention training technique: A component study
  62. Do people with psychosis engage in unhelpful metacognitive coping strategies? A test of the validity of the Cognitive Attentional Syndrome (CAS) in a clinical sample
  63. Group Metacognitive Therapy vs. Mindfulness Meditation Therapy in a Transdiagnostic Patient Sample: A Randomised Feasibility Trial
  64. The effect of thought importance on stress responses: a test of the metacognitive model
  65. Attentional avoidance increases voice hearing in an analogue task in people with psychosis: An experimental study
  66. The role of cognitive and metacognitive factors in non-clinical paranoia and negative affect
  67. Individual differences in metacognitive knowledge contribute to psychological vulnerability more than the presence of a mental disorder does
  68. Social cognition and metacognition in social anxiety: A systematic review
  69. Are experiences of psychosis associated with unhelpful metacognitive coping strategies? A systematic review of the evidence
  70. Metacognitive Therapy in Major Depression: An Open Trial of Comorbid Cases
  71. Predictors of Biased Self-perception in Individuals with High Social Anxiety: The Effect of Self-consciousness in the Private and Public Self Domains
  72. Social anxiety and work status: the role of negative metacognitive beliefs, symptom severity and cognitive-behavioural factors
  73. An exploration of the relationship between use of safety-seeking behaviours and psychosis: A systematic review and meta-analysis
  74. Testing the metacognitive model against the benchmark CBT model of social anxiety disorder: Is it time to move beyond cognition?
  75. ‘You've got your own demons that you've got to fight every day’: A qualitative exploration of how people respond to the experience of psychosis
  76. Cognitive and metacognitive predictors of symptom improvement following treatment for social anxiety disorder: A secondary analysis from a randomized controlled trial
  77. Measuring common responses to psychosis: Assessing the psychometric properties of a new measure
  78. Metacognitive beliefs and rumination as predictors of anger: A prospective study
  79. Metacognitive Therapy for Depression in Adults: A Waiting List Randomized Controlled Trial with Six Months Follow-Up
  80. Rumination
  81. A meta-analysis of metacognitive beliefs as implicated in the self-regulatory executive function model in clinical psychosis
  82. The role of unhelpful metacognitive beliefs in psychosis: Relationships with positive symptoms and negative affect
  83. Experimental modification of perspective on thoughts and metacognitive beliefs in alcohol use disorder
  84. Is metacognition a causal moderator of the relationship between catastrophic misinterpretation and health anxiety? A prospective study
  85. Can the attention training technique turn one marshmallow into two? Improving children's ability to delay gratification
  86. SSRI vs Cognitive therapy in patients with social phobia
  87. Metacognitive beliefs moderate the relationship between catastrophic misinterpretation and health anxiety
  88. Metacognition in addictive behaviors
  89. The Metacognitions about Smoking Questionnaire: Development and psychometric properties
  90. Early trauma, negative affect, and anxious attachment: the role of metacognition
  91. Emotion regulation as a mediator in the relationship between attachment and depressive symptomatology: A systematic review
  92. Unique Contributions of Metacognition and Cognition to Depressive Symptoms
  93. Refraining from Intrusive Thoughts is Strategy Dependent: A Comment on Sugiura, et al. and a Preliminary Informal Test of Detached Mindfulness, Acceptance, and other Strategies
  94. An open trial of group metacognitive therapy for depression in Norway
  95. How to Deal with Negative Thoughts? A Preliminary Comparison of Detached Mindfulness and Thought Evaluation in Socially Anxious Individuals
  96. Metacognitive Therapy Versus Prolonged Exposure in Adults with Chronic Post-traumatic Stress Disorder: A Parallel Randomized Controlled Trial
  97. Schizophrenia and Metacognition: An Investigation of Course of Illness and Metacognitive Beliefs Within a First Episode Psychosis
  98. A Randomised Controlled Study of the Effects of the Attention Training Technique on Traumatic Stress Symptoms, Emotional Attention Set Shifting and Flexibility
  99. Group Metacognitive Therapy for Severe Antidepressant and CBT Resistant Depression: A Baseline-Controlled Trial
  100. Metacognitive therapy in people with a schizophrenia spectrum diagnosis and medication resistant symptoms: A feasibility study
  101. Metacognitive therapy in recurrent depression: A case replication series in Denmark
  102. Attention Training Reduces Intrusive Thoughts Cued by a Narrative of Stressful Life Events: A Controlled Study
  103. Metacognitive Therapy for Generalized Anxiety Disorder: Nature, Evidence and an Individual Case Illustration
  104. Advances in Metacognitive Therapy
  105. Metacognitive beliefs in adolescents with an at-risk mental state for psychosis
  106. An experimental manipulation of metacognition: A test of the metacognitive model of obsessive-compulsive symptoms
  107. Metacognitive Therapy in Treatment-Resistant Psychosis: A Multiple-Baseline Study
  108. Does Metacognition Make a Unique Contribution to Health Anxiety When Controlling for Neuroticism, Illness Cognition, and Somatosensory Amplification?
  109. A Multiple‐Baseline Study of the Effects Associated With Metacognitive Therapy in Postpartum Depression
  110. Automatic thoughts and meta-cognition as predictors of depressive or anxious symptoms: A prospective study of two trajectories
  111. On the relationship between temperament, metacognition, and anxiety: independent and mediated effects
  112. Metacognition and Obsessive-Compulsive Symptoms: The Contribution of Thought-Fusion Beliefs and Beliefs about Rituals
  113. Development and Preliminary Validation of the Thought Control Questionnaire for Adolescents (TCQ-A)
  114. Metacognitive therapy in treatment-resistant depression: A platform trial
  115. A Triphasic Metacognitive Formulation of Problem Drinking
  116. Treating Posttraumatic Stress Disorder With Metacognitive Therapy: A Preliminary Controlled Trial
  117. Metacognitive Therapy
  118. Social Metacognition
  119. Metacognitions and negative emotions as predictors of symptom severity in chronic fatigue syndrome
  120. The temporal precedence of metacognition in the development of anxiety and depression symptoms in the context of life-stress: A prospective study
  121. Meta-Cognitive Therapy Without Metacognition: A Case of ADHD
  122. Metacognition and persecutory delusions: Tests of a metacognitive model in a clinical population and comparisons with non-patients
  123. Conceptual Models of Generalized Anxiety Disorder
  124. Generalized anxiety disorder
  125. Metacognitions across the continuum of drinking behaviour
  126. Association Between Abnormal Psychosocial Situations in Childhood, Generalized Anxiety Disorder and Oppositional Defiant Disorder
  127. A pilot randomized trial of metacognitive therapy vs applied relaxation in the treatment of adults with generalized anxiety disorder
  128. Metacognition, memory disorganization and rumination in posttraumatic stress symptoms
  129. An empirical test of the metacognitive model of obsessive-compulsive symptoms: Replication and extension
  130. Metacognitive Theory and Therapy for Worry and Generalized Anxiety Disorder: Review and Status
  131. Metacognitions as a predictor of drinking status and level of alcohol use following CBT in problem drinkers: A prospective study
  132. Treatment Resistant Anxiety Disorders
  133. The Relationship among Metacognitions, Attentional Control, and State Anxiety
  134. A metacognitive model of problem drinking
  135. Imagery rescripting as a brief stand-alone treatment for depressed patients with intrusive memories
  136. A Prospective Test of the Clinical Metacognitive Model of Rumination and Depression
  137. Metacognition and Cognition as Predictors of Obsessive-Compulsive Symptoms: A Prospective Study
  138. An empirical test of the metacognitive model of obsessive-compulsive symptoms: Fusion beliefs, beliefs about rituals, and stop signals
  139. Change in metacognitions predicts outcome in obsessive–compulsive disorder patients undergoing treatment with exposure and response prevention
  140. Metacognitive Therapy: Cognition Applied To Regulating Cognition
  141. Psychometric characteristics of the Penn State Worry Questionnaire and Metacognitions Questionnaire-30 and metacognitive predictors of worry and obsessive-compulsive symptoms in a Turkish sample
  142. Psychological Models of Worry and Generalized Anxiety Disorder
  143. Treating Bulimia Nervosa and Binge Eating
  144. Measuring metacognitions associated with emotional distress: Factor structure and predictive validity of the metacognitions questionnaire 30
  145. Psychological factors predicting stress symptoms: Metacognition, thought control, and varieties of worry
  146. Metacognitive therapy for obsessive–compulsive disorder: A case series
  147. Cognitive Therapy for Generalised Anxiety Disorder
  148. Cognitive Therapy for Social Phobia
  149. Identifying Specific Interpretations and Exploring the Nature of Safety Behaviours for People Who Hear Voices: An Exploratory Study
  150. Belief domains of the Obsessive Beliefs Questionnaire-44 (OBQ-44) and their specific relationship with obsessive–compulsive symptoms
  151. Metacognition, perceived stress, and negative emotion
  152. Metacognitive beliefs about alcohol use: Development and validation of two self-report scales
  153. Chronic PTSD Treated With Metacognitive Therapy: An Open Trial
  154. Metacognitive Therapy in Recurrent and Persistent Depression: A Multiple-Baseline Study of a New Treatment
  155. “I’ll believe it when I can see it”: Imagery rescripting of intrusive sensory memories in depression
  156. Intrusive images and memories in major depression
  157. Metacognition as a mediator of the relationship between emotion and smoking dependence
  158. Metacognitive beliefs across the continuum of psychosis: Comparisons between patients with psychotic disorders, patients at ultra-high risk and non-patients
  159. The relative contribution of metacognitive beliefs and expectancies to drinking behaviour
  160. Relationships between worry, psychotic experiences and emotional distress in patients with schizophrenia spectrum diagnoses and comparisons with anxious and non-patient groups
  161. Belief disconfirmation versus habituation approaches to situational exposure in panic disorder with agoraphobia: A pilot study
  162. The Attention Training Technique: Theory, Effects, and a Metacognitive Hypothesis on Auditory Hallucinations
  163. Cognition About Cognition: Metacognitive Therapy and Change in Generalized Anxiety Disorder and Social Phobia
  164. Cognitive therapy for bulimia nervosa: an A-B replication series
  165. Assessing Eating Disorder Thoughts and Behaviors: The Development and Preliminary Evaluation of Two Questionnaires
  166. Metacognitions in Problem Drinkers
  167. Case Formulation in Cognitive Behaviour Therapy
  168. Does maternal psychopathology discriminate between children with DSM-IV generalised anxiety disorder or oppositional defiant disorder? The predictive validity of maternal axis I and axis II psychopathology
  169. Metacognitive therapy for generalized anxiety disorder: An open trial
  170. Cognitive Vulnerability to Emotional Disorders
  171. Number of bodily symptoms predicts outcome more accurately than health anxiety in patients attending neurology, cardiology, and gastroenterology clinics
  172. Cognitive Processes, Reasoning Biases and Persecutory Delusions: A Comparative Study
  173. Worry and its Psychological Disorders
  174. Metacognitions about alcohol use in problem drinkers
  175. Post-traumatic stress symptoms: Tests of relationships with thought control strategies and beliefs as predicted by the metacognitive model
  176. Detached Mindfulness In Cognitive Therapy: A Metacognitive Analysis And Ten Techniques
  177. How effective are cognitive and behavioral treatments for obsessive–compulsive disorder? A clinical significance analysis
  178. Distress in Parkinson's disease: Contributions of disease factors and metacognitive style
  179. Experimental modification of beliefs in obsessive–compulsive disorder: a test of the metacognitive model
  180. The Metacognitive Model of GAD: Assessment of Meta-Worry and Relationship With DSM-IV Generalized Anxiety Disorder
  181. Metacognitions, emotion and alcohol use
  182. Obsessive-compulsive symptoms: the contribution of metacognitions and responsibility
  183. Metacognitive therapy for PTSD: a preliminary investigation of a new brief treatment
  184. Interpretations of voices in patients with hallucinations and non-patient controls: a comparison and predictors of distress in patients
  185. Childhood adversity and frequent medical consultations
  186. Metacognitive therapy for PTSD: A core treatment manual
  187. Psychological treatment of social phobia
  188. Analysis of thin AlN carrier exclusion layers in AlGaN/GaN microwave heterojunction field-effect transistors
  189. A short form of the metacognitions questionnaire: properties of the MCQ-30
  190. A cognitive model of bulimia nervosa
  191. Dose meta-cognition or responsibility predict obsessive–compulsive symptoms: a test of the metacognitive model
  192. Development and preliminary validation of the Meta-cognitions Questionnaire—Adolescent Version
  193. Religion and mental health: Towards a cognitive-behavioural framework
  194. A comparison of metacognitions in patients with hallucinations, delusions, panic disorder, and non-patient controls
  195. Depressive Rumination
  196. Cognitive and emotional predictors of predisposition to hallucinations in non-patients
  197. Worry, Metacognition, and GAD: Nature, Consequences, and Treatment
  198. The role of metacognitive beliefs in auditory hallucinations
  199. Death beliefs, superstitious beliefs and health anxiety
  200. GAD, Metacognition, and Mindfulness: An Information Processing Analysis
  201. Emotional Disorders and Metacognition
  202. Effects of heart rate information on anxiety, perspective taking, and performance in high and low social-evaluative anxiety
  203. GAD, metacognition, and mindfulness: An information processing analysis.
  204. Brief cognitive therapy for social phobia: a case series
  205. An experimental investigation of thought suppression and anxiety in children
  206. Metacognitive beliefs about rumination in recurrent major depression
  207. Emotional, Cognitive, and Behavioral Characteristics of Medical Outpatients
  208. Exercising for the wrong reasons: relationships among eating disorder beliefs, dysfunctional exercise beliefs and coping
  209. Further tests of a cognitive model of generalized anxiety disorder: Metacognitions and worry in GAD, panic disorder, social phobia, depression, and nonpatients
  210. Positive beliefs about depressive rumination: Development and preliminary validation of a self-report scale
  211. Prevalence and predictors of acute stress disorder and PTSD following road traffic accidents: Thought control strategies and social support
  212. Social phobic interoception: effects of bodily information on anxiety, beliefs and self-processing
  213. Thought control strategies in schizophrenia: a comparison with non-patients
  214. ERRATUM
  215. The prediction of parasuicide repetition in a high-risk group
  216. A Cognitive Model of Generalized Anxiety Disorder
  217. The Thought Control Questionnaire – psychometric properties in a clinical sample, and relationships with PTSD and depression
  218. The observer perspective: biased imagery in social phobia, agoraphobia, and blood/injury phobia
  219. An experimental investigation of the role of safety-seeking behaviours in the maintenance of panic disorder with agoraphobia
  220. Preliminary tests of a cognitive model of generalized anxiety disorder
  221. Brief cognitive therapy for panic disorder: A randomized controlled trial.
  222. The Manchester bombing: Providing a rational response
  223. Relationships between worry, obsessive–compulsive symptoms and meta-cognitive beliefs
  224. Assessment of beliefs in exercise dependence: The development and preliminary validation of the exercise beliefs questionnaire
  225. How do I look with my minds eye: perspective taking in social phobic imagery
  226. Effects of attention training on hypochondriasis: a brief case series
  227. Social phobia: Effects of external attention on anxiety, negative beliefs, and perspective taking
  228. Beliefs about Worry and Intrusions: The Meta-Cognitions Questionnaire and its Correlates
  229. The Eating Disorder Belief Questionnaire: Preliminary development
  230. Anxiety and cognition
  231. Modelling cognition in emotional disorder: The S-REF model
  232. Worry and the incubation of intrusive images following stress
  233. Social phobia: The role of in-situation safety behaviors in maintaining anxiety and negative beliefs
  234. Qualitative dimensions of normal worry and normal obsessions: A comparative study
  235. The thought control questionnaire: A measure of individual differences in the control of unwanted thoughts
  236. Panic disorder in association with relaxation induced anxiety: An attentional training approach to treatment
  237. Metacognitive Therapy for Worry and Generalised Anxiety Disorder
  238. Metacognitive Therapy for Depressive Rumination
  239. Nature, Functions, and Beliefs about Depressive Rumination
  240. Rumination, Depression, and Metacognition: the S-REF Model
  241. The Anxious Thoughts Inventory and Related Measures of Metacognition and Worry
  242. The Metacognitive Model of Worry and Generalised Anxiety Disorder